A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease - Wikidata - awgldk - TriplyDB

A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease

A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease

http://www.wikidata.org/entity/Q33684167

about

High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.Nutritional vitamin D use in chronic kidney disease: a survey of pediatric nephrologists.Vitamin D and inflammatory diseases.Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials.The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.Vitamin D therapy in chronic kidney disease and end stage renal disease.Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review.Safety and tolerability of paricalcitol in patients with chronic kidney disease.Advances in pharmacotherapy for secondary hyperparathyroidism.Calcifediol to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms?Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.Which vitamin D in CKD-MBD? The time of burning questions.Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation.The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease.The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4: results of a 12-week double-blind, randomized, controlled study.Is there a role or target value for nutritional vitamin D in chronic kidney disease?Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies

P2860

Q30524139-4CCFBF65-79A6-4188-9907-283C9B6174B6 Q33703957-F5B24291-CF29-46BF-BB74-F332D177DA96 Q33737184-238E63E8-2BA4-42F9-91CF-208FD65CB50A Q33806322-DBCE3C9B-660C-4005-916A-0476FD4939DC Q34497264-EB5EF0A8-3F6D-4FC7-A59C-472A0F5AC962 Q34692107-68A32DB2-7ACC-41FE-810D-43CD5A9DAC5E Q35119028-EF85C9A1-48F3-4F96-BCD5-DA2F9255E164 Q35245052-79677FFE-CCF5-429E-8794-B0A9400ECCFC Q35758581-87961E1C-F79F-4CFA-A54E-5208D10B984F Q36187587-FC15D40D-A371-4FCB-9E78-D746782437C8 Q38101995-8CB8EFD9-F8EF-4B3F-B5A9-5A76F52BB560 Q38544533-C4572A36-0886-429F-B5CA-EFE6F1D9B7D6 Q38605841-26F6C149-D78C-4103-9830-9B25C2F9D26C Q38803449-79E826B9-8B17-44E9-B5B3-2EB55484F10F Q38827273-978BB2F7-D969-47F4-8184-E36294737DD8 Q42233431-64C8A430-6661-43A2-A51D-CC1390401978 Q42562972-F3E665F5-BE1A-4CB3-93EE-9768FC072B93 Q42727580-78EC774C-77BB-4422-9E06-1ADF5C301E20 Q44487823-14C3BF79-99E6-4477-B659-C99154811CA6 Q47302709-504D7D43-C24F-419E-956D-2F1A09A84A03 Q48055168-72930C37-48F2-4251-8579-56D74DF07A5A Q50101289-88ADF229-928C-43E8-B70F-B0D07CDBB54D Q50952523-2F280457-10EE-45DC-B81D-14CA3AD8347A Q51782027-035DF8A5-0202-4109-B55C-E691B1638734 Q53342883-F74E2CED-8C90-4420-8699-CD0BDAF64ADE Q58768080-B27681DF-0AA5-49DA-86E4-FC565F60F115

P2860

A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease

http://www.wikidata.org/entity/Q33684167

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

A randomized trial of cholecal ...... mone in chronic kidney disease

@ast

A randomized trial of cholecal ...... mone in chronic kidney disease

@en

type

label

A randomized trial of cholecal ...... mone in chronic kidney disease

@ast

A randomized trial of cholecal ...... mone in chronic kidney disease

@en

prefLabel

A randomized trial of cholecal ...... mone in chronic kidney disease

@ast

A randomized trial of cholecal ...... mone in chronic kidney disease

@en

P1433

Q33684167-3F925FD5-CCB4-45A2-AE04-5656E9A55D5E

P1476

Q33684167-4CC68626-E9A6-4394-B463-13F07F2F8E0C

P2093

Q33684167-4F4AFB1D-69AF-42FB-B293-1085297AF4F7

Q33684167-DC865C04-53A3-4A6E-9235-5048F98F5527

Q33684167-DE68C5AB-2867-417D-8081-DC6F78E4751D

Q33684167-E4304EF0-B868-4F74-838D-CF300B9AB904

Q33684167-E9C43E61-2099-4EC1-953C-B00494F48DCB

P2860

Q33684167-0412A853-E0D8-4048-BACE-1C767AD81691

Q33684167-19957AD3-8617-4C17-BB34-67E3B030AAAF

Q33684167-1D6C1AD0-C201-40FD-B0A5-33127590522A

Q33684167-31C1163D-81A4-4D30-92B8-478019C7FE32

Q33684167-3E234575-C59B-4276-AFBF-74B7544C8BF9

Q33684167-4160ADE2-070E-480D-87D9-5A61CECE47F5

Q33684167-47218015-94EB-4301-90FD-BEE9708C1B8A

Q33684167-487DA4FE-8128-43D7-9052-B072E6DB27DE

Q33684167-7E55BC9C-4CBA-406E-8018-E32615C3D2CC

Q33684167-8310E047-1EC9-44BA-9FC1-950DC087F667

P304

Q33684167-6E398B1B-D2AF-4412-9855-82FB47E5E02D

P31

Q33684167-84839691-42D7-49E9-9F77-1C5A45B9E4E8

P356

Q33684167-9EBC03C1-F56C-4EC2-9BE4-07EBECE95B42

P433

Q33684167-3A16428A-5085-48F8-94C9-82218869D727

P478

Q33684167-D49EEB8B-B648-4324-AAEC-50242BE5DDE9

P577

Q33684167-D6E96777-222F-408D-95F4-A0048B9A0FCE

P5875

Q33684167-7EB083C7-9938-46A4-AA68-25401E0A8F07

P698

Q33684167-54247BA8-36B6-4D4F-975C-9BD310119AA3

P932

Q33684167-51E51EF2-99CC-4E45-83EA-06CFDAA22FEE

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

A randomized trial of cholecal ...... mone in chronic kidney disease

@en

P2093

Akber Saifullah

http://www.w3.org/2001/XMLSchema#string

Robert E LaClair

http://www.w3.org/2001/XMLSchema#string

Sharon M Moe

http://www.w3.org/2001/XMLSchema#string

Sohail A Usman

http://www.w3.org/2001/XMLSchema#string

Zhangsheng Yu

http://www.w3.org/2001/XMLSchema#string

P2860

1alpha-Hydroxylase and the action of vitamin D.

Self-monitoring of blood pressure at home: how many measurements are needed?

Hypovitaminosis D in chronic kidney disease.

Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.

Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.

Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study.

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

P304

299-306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.07131009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40894733

http://www.w3.org/2001/XMLSchema#string

P698

20056760

http://www.w3.org/2001/XMLSchema#string

P932

2827596

http://www.w3.org/2001/XMLSchema#string